USA Compression Partners, LP (USAC) Key Metrics
USAC valuation today
Trailing 12 months · as of October 18, 2026- Market cap
- $3.70B
- Enterprise value
- $6.69B
- P/E (TTM)
- 24.1 10-yr median 53.9
- Forward P/E
- 16.9
- PEG ratio
- —
- Price / sales
- 3.1 10-yr median 2.7
- Price / book
- 13.0 10-yr median 2.3
- EV / EBITDA
- 10.0 10-yr median 9.5
- Dividend yield
- 8.23% $2.10 a year
- Beta
- 0.25
USAC key metrics, 2016–2025
Fiscal year ended December 31, 2025 · U.S. dollarsUSAC valuation Price multiples at each fiscal year-end price.
USAC returns How much profit the business earns on the capital it uses.
USAC per-share figures Results divided by the shares outstanding at year-end.
USAC financial health Debt, liquidity and how easily interest is covered.
USAC efficiency & capital use Working capital cycle and where the cash goes.
USAC valuation history
USAC returns on capital
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
USAC debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
USAC cash returned to shareholders
USAC price vs earnings per share
USAC key metrics
2016–2025| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||
| Market capitalization | $2.79B | $2.70B | $2.30B | $1.91B | $1.69B | $1.32B | $1.75B | $1.42B | $1.02B | $953.4M |
| Enterprise value | $5.33B | $5.22B | $4.65B | $4.04B | $3.71B | $3.27B | $3.63B | $3.18B | $1.81B | $1.64B |
| P/E ratio | 25.1 | 27.1 | 33.7 | 63.0 | 164.8 | — | 44.8 | — | 89.4 | 73.7 |
| Price / sales | 2.8 | 2.8 | 2.7 | 2.7 | 2.7 | 2.0 | 2.5 | 2.4 | 3.6 | 3.6 |
| Price / book | — | 97.2 | 12.6 | 5.3 | 2.9 | 1.6 | 1.1 | — | 1.6 | 1.3 |
| Price / free cash flow | 10.1 | 19.8 | 68.9 | 15.1 | 7.7 | 7.2 | 13.5 | — | 54.5 | 18.2 |
| Price / operating cash flow | 7.1 | 7.9 | 8.5 | 7.3 | 6.4 | 4.5 | 5.8 | 6.3 | 8.2 | 9.2 |
| EV / sales | 5.3 | 5.5 | 5.5 | 5.7 | 5.9 | 4.9 | 5.2 | 5.4 | 6.4 | 6.2 |
| EV / EBITDA | 9.1 | 9.2 | 9.5 | 9.9 | 9.7 | 8.1 | 9.1 | 11.4 | — | 12.8 |
| EV / free cash flow | 19.2 | 38.2 | 139.4 | 31.9 | 16.8 | 17.8 | 28.0 | — | 96.3 | 31.2 |
| Earnings yield | 4.0% | 3.7% | 3.0% | 1.6% | 0.6% | −45.2% | 2.2% | −0.7% | 1.1% | 1.4% |
| Free cash flow yield | 9.9% | 5.1% | 1.5% | 6.6% | 13.0% | 14.0% | 7.4% | −2.8% | 1.8% | 5.5% |
| Dividend yield | 9.6% | 9.8% | 11.2% | 13.4% | 15.1% | 19.2% | 13.9% | 11.7% | 11.2% | 9.2% |
| Shareholder yield (dividends + buybacks) | 9.6% | 9.8% | 11.2% | 13.4% | 15.1% | 19.2% | 13.9% | 11.7% | 11.2% | 9.2% |
| Share price at fiscal year-end | $23.00 | $23.56 | $22.83 | $19.53 | $17.45 | $13.60 | $18.14 | $12.98 | $16.54 | $17.30 |
| Per share | ||||||||||
| Revenue per share | $8.23 | $8.30 | $8.41 | $7.21 | $6.52 | $6.90 | $7.23 | $5.35 | $4.53 | $4.83 |
| Earnings per share | $0.92 | $0.87 | $0.68 | $0.31 | $0.11 | −$6.14 | $0.41 | −$0.10 | $0.19 | $0.23 |
| Operating cash flow per share | $3.25 | $2.98 | $2.70 | $2.67 | $2.73 | $3.03 | $3.11 | $2.07 | $2.02 | $1.88 |
| Free cash flow per share | $2.28 | $1.19 | $0.33 | $1.29 | $2.27 | $1.90 | $1.34 | −$0.37 | $0.30 | $0.95 |
| Cash per share | $0.07 | $0.00 | $0.00 | $0.00 | −$0.19 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Book value per share | −$0.93 | $0.24 | $1.82 | $3.69 | $5.96 | $8.42 | $17.16 | −$7.52 | $10.25 | $13.24 |
| Tangible book value per share | −$2.47 | −$1.65 | −$0.62 | $0.88 | $2.82 | $4.97 | $6.99 | −$16.78 | $8.51 | $11.22 |
| Dividends per share | $2.20 | $2.32 | $2.56 | $2.62 | $2.63 | $2.62 | $2.51 | $1.52 | $1.85 | $1.59 |
| Capex per share | $0.97 | $1.79 | $2.37 | $1.37 | $0.47 | $1.13 | $1.77 | $2.44 | $1.71 | $0.93 |
| Debt per share | $21.03 | $22.01 | $23.35 | $21.75 | $20.57 | $20.17 | $19.41 | $16.10 | $12.66 | $12.44 |
| Shares outstanding | 121.3M | 114.5M | 100.7M | 97.8M | 97.1M | 96.8M | 96.6M | 109.3M | 61.8M | 55.1M |
| Change in shares outstanding | +5.9% | +13.7% | +3.0% | +0.7% | +0.3% | +0.2% | −11.6% | +76.7% | +12.2% | +14.4% |
| Returns & profitability | ||||||||||
| Return on equity (ROE) | — | 94.5% | 25.1% | 6.5% | 1.5% | −48.1% | 9.4% | — | 1.7% | 1.8% |
| Return on invested capital (ROIC) | 12.2% | 11.3% | 9.1% | 6.4% | 4.8% | −11.7% | 7.1% | 4.4% | 2.5% | 1.9% |
| Return on assets (ROA) | 4.1% | 3.6% | 2.5% | 1.1% | 0.4% | −17.8% | 1.0% | −0.4% | 0.8% | 0.9% |
| Return on tangible assets | 4.6% | 3.9% | 2.7% | 1.3% | 0.4% | −22.7% | 1.4% | −0.4% | 0.8% | 1.0% |
| Free cash flow margin | 27.8% | 14.4% | 3.9% | 17.9% | 34.8% | 27.6% | 18.5% | −6.9% | 6.7% | 19.7% |
| Income quality (OCF / net income) | 3.54 | 3.43 | 3.98 | 8.60 | 25.82 | — | 7.68 | — | 10.90 | 8.02 |
| Financial health | ||||||||||
| Total debt | $2.55B | $2.52B | $2.35B | $2.13B | $2.00B | $1.95B | $1.87B | $1.76B | $782.9M | $685.4M |
| Cash & short-term investments | $8.6M | $14,000 | $11,000 | $35,000 | −$18.6M | $2,000 | $10,000 | $99,000 | $47,000 | $65,000 |
| Net debt | $2.54B | $2.52B | $2.35B | $2.13B | $2.01B | $1.95B | $1.87B | $1.76B | $782.9M | $685.3M |
| Debt / equity | — | 90.78 | 12.84 | 5.89 | 3.45 | 2.40 | 1.13 | — | 1.24 | 0.94 |
| Debt / assets | 0.97 | 0.92 | 0.86 | 0.80 | 0.72 | 0.66 | 0.50 | 0.47 | 0.52 | 0.47 |
| Net debt / EBITDA | 4.32 | 4.44 | 4.80 | 5.20 | 5.27 | 4.86 | 4.69 | 6.29 | — | 5.35 |
| Current ratio | 1.27 | 1.23 | 1.21 | 1.07 | 1.09 | 1.17 | 1.22 | 1.46 | 1.04 | 1.29 |
| Quick ratio | 0.55 | 0.53 | 0.60 | 0.53 | 0.64 | 0.67 | 0.73 | 0.86 | 0.59 | 0.77 |
| Interest coverage | 1.7 | 1.5 | 1.4 | 1.2 | 1.1 | -3.6 | 1.3 | 0.8 | 1.5 | 1.6 |
| Working capital | $49.7M | $44.3M | $38.9M | $12.8M | $17.3M | $29.3M | $41.5M | $68.1M | $3.1M | $16.6M |
| Invested capital | $2.43B | $2.55B | $2.53B | $2.49B | $2.59B | $2.77B | $3.53B | $937.4M | $1.42B | $1.41B |
| Tangible asset value | −$299.4M | −$188.5M | −$62.6M | $86.0M | $274.0M | $481.2M | $675.3M | $844.2M | $526.3M | $618.5M |
| Net current asset value | −$2.50B | −$2.48B | −$2.33B | −$2.12B | −$1.98B | −$1.93B | −$1.84B | −$1.70B | −$781.3M | −$669.9M |
| Graham number | — | $2.18 | $5.27 | $5.08 | $3.77 | — | $12.51 | — | $6.53 | $8.36 |
| Graham net-net per share | −$21.40 | −$22.57 | −$24.09 | −$22.45 | −$21.78 | −$21.08 | −$19.92 | −$16.28 | −$13.12 | −$12.65 |
| Capital allocation | ||||||||||
| Dividends paid | $266.9M | $265.2M | $257.8M | $256.2M | $255.1M | $253.4M | $242.9M | $166.6M | $114.1M | $87.7M |
| Share buybacks (net) | — | — | — | — | — | — | — | $0 | $0 | $0 |
| Dividend payout ratio | 239.7% | 266.4% | 377.6% | 845.0% | — | — | 620.8% | — | 997.5% | 678.2% |
| Dividends + buybacks / free cash flow | 96.4% | 194.3% | 772.7% | 202.7% | 115.8% | 137.6% | 187.7% | — | 608.4% | 167.2% |
| Capex / revenue | 11.8% | 21.6% | 28.2% | 19.0% | 7.1% | 16.3% | 24.5% | 45.6% | 37.8% | 19.3% |
| Capex / operating cash flow | 29.7% | 60.0% | 87.7% | 51.5% | 17.0% | 37.2% | 56.9% | 117.8% | 85.0% | 49.4% |
| Capex / depreciation | 0.41 | 0.77 | 0.97 | 0.57 | 0.19 | 0.46 | 0.74 | 1.25 | 0.64 | 0.55 |
| Stock-based compensation / revenue | 0.4% | 1.7% | 2.6% | 2.3% | 2.5% | 1.3% | 1.5% | 2.0% | 4.2% | 3.9% |
| SG&A / revenue | 6.6% | 7.6% | 8.5% | 8.7% | 8.9% | 9.0% | 9.6% | 52.1% | 53.7% | 16.7% |
| Efficiency | ||||||||||
| Days sales outstanding | 31.4 | 35.4 | 38.7 | 39.4 | 39.0 | 55.6 | 68.9 | 52.3 | 53.3 | 49.9 |
| Days of inventory on hand | 79.8 | 147.0 | 135.4 | 142.1 | 163.0 | 159.1 | 72.0 | 52.2 | 60.1 | 49.0 |
| Days payables outstanding | 16.5 | 39.6 | 48.8 | 45.8 | 34.5 | 31.8 | 18.3 | 18.8 | 31.7 | 37.4 |
| Cash conversion cycle (days) | 94.7 | 142.8 | 125.3 | 135.7 | 167.5 | 183.0 | 122.7 | 85.7 | 81.8 | 61.5 |
| Receivables turnover | 11.63 | 10.30 | 9.44 | 9.26 | 9.37 | 6.56 | 5.29 | 6.97 | 6.85 | 7.31 |
| Payables turnover | 22.17 | 9.21 | 7.48 | 7.98 | 10.58 | 11.49 | 19.99 | 19.38 | 11.53 | 9.76 |
| Inventory turnover | 4.57 | 2.48 | 2.70 | 2.57 | 2.24 | 2.29 | 5.07 | 7.00 | 6.07 | 7.45 |
| Asset turnover | 0.37 | 0.35 | 0.31 | 0.26 | 0.22 | 0.20 | 0.19 | 0.22 | 0.19 | 0.18 |
| Average receivables | $85.8M | $92.3M | $89.6M | $76.1M | $67.5M | $101.8M | $131.9M | $83.8M | $40.9M | $36.4M |
| Average payables | $27.7M | $33.5M | $37.5M | $28.9M | $18.0M | $17.6M | $23.0M | $22.1M | $16.6M | $18.5M |
| Average inventory | $134.2M | $124.3M | $104.2M | $89.8M | $85.2M | $88.3M | $90.5M | $61.2M | $31.5M | $24.2M |
| Intangibles / total assets | 7.1% | 7.9% | 9.0% | 10.3% | 11.0% | 11.3% | 26.3% | 26.8% | 7.2% | 7.5% |
Computed from USAC's annual financial statements (latest annual report filed February 17, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
USAC valuation and financial ratios
At the end of fiscal 2025 (December 31, 2025), USA Compression Partners traded at 25.1 times earnings, against a 10-year median of 53.9. Based on the latest twelve months, the trailing P/E is 24.1 and the forward P/E is 16.9. USA Compression Partners earned a return on invested capital of 12.2% in fiscal 2025. It ended the year with $2.6 billion of debt and $8.6 million in cash and short-term investments, net debt of $2.5 billion. It returned $266.9 million to shareholders: $266.9 million in dividends and $0 in share buybacks, 96% of free cash flow. The share count rose 120.1% from 55.1M to 121.3M over 9 years.
See the USAC income statement, the USAC chart for price history, or the USAC stock overview for the latest quote and news.
USAC key metrics FAQ
What is USA Compression Partners's P/E ratio?
USA Compression Partners's trailing P/E ratio is 24.1 based on the last twelve months of earnings (as of October 18, 2026), and its forward P/E is 16.9. At the end of fiscal 2025 it was 25.1, compared with a 10-year median of 53.9.
What is USA Compression Partners's EV/EBITDA?
USA Compression Partners's enterprise value was 9.1 times EBITDA at the end of fiscal 2025 (enterprise value $5.3 billion, EBITDA $588.4 million); the current EV/EBITDA is 10.0.
What is USA Compression Partners's ROIC?
USA Compression Partners's return on invested capital was 12.2% in fiscal 2025, using after-tax operating income divided by average debt plus equity minus cash.
How much debt does USA Compression Partners have?
USA Compression Partners had total debt of $2.6 billion at the end of fiscal 2025 and $2.5 billion of net debt (4.32 times EBITDA).
What is USA Compression Partners's dividend yield?
USA Compression Partners's forward dividend yield is 8.23%. USA Compression Partners paid $266.9 million in dividends in fiscal 2025 ($2.20 per share), a payout ratio of 239.7%.
What is USA Compression Partners's free cash flow yield?
USA Compression Partners generated $277.0 million of free cash flow in fiscal 2025, a free cash flow yield of 9.9% on its market value at year-end ($2.8 billion).
What is USA Compression Partners's current ratio?
USA Compression Partners's current ratio was 1.27 at the end of fiscal 2025: current assets were 1.27 times current liabilities.